Aravind

How GSK's access to medicine plans will shake up Big Pharma

Author: Oliver Balch, Ethical Corporation

Andrew Witty…the chief executive of…GlaxoSmithKline…has now sent out signals that could radically alter Big Pharma…GSK, he pledged, would slash prices for a host of medicines, share patents for dozens of compounds and invest in health infrastructure....

▹Read more

• Related companies: Aravind GlaxoSmithKline Merck Novartis Pfizer